Predict your next investment

HEALTHCARE | Biotechnology
selexagen.com

See what CB Insights has to offer

Executives

1

Board of Directors

1

Selexagen Therapeutics Board of Director

1 Board of directors

Selexagen Therapeutics has 1 board of directors, including Scott Glenn.

Name

Firm

Work History

Other Seats

Scott Glenn

Selexagen Therapeutics

Name

Scott Glenn

Firm

Work History

Other Seats

Selexagen Therapeutics

Selexagen Therapeutics Management Team

1 Team Member

Selexagen Therapeutics has 1 executive. Selexagen Therapeutics's founder is Patrick M. O'Connor.

Name

Work History

Title

Status

Patrick M. O'Connor

Ardea Biosciences, Pfizer, and National Cancer Institute

Founder

Current

Name

Patrick M. O'Connor

Work History

Ardea Biosciences, Pfizer, and National Cancer Institute

Title

Founder

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.